EUKINES Wearable Plantar-Pressure Insole System for Rehabilitation After Total Hip Arthroplasty
EUKINES
Prospective, Randomized, Partially Blinded, Multicenter Non-Inferiority Trial of the EUKINES Wearable Plantar-Pressure Insole Gait-Analysis System for Postoperative Rehabilitation After Primary Total Hip Arthroplasty
2 other identifiers
interventional
200
1 country
1
Brief Summary
This study evaluates a wearable plantar-pressure insole system (EUKINES) designed to support gait training during postoperative rehabilitation after primary total hip arthroplasty (THA). The trial will include 200 adults who are randomly assigned to one of four rehabilitation programs: EUKINES with real-time biofeedback, EUKINES without biofeedback, a certified commercial reference system with biofeedback, or standard rehabilitation without any gait-analysis device. All participants will receive a structured 6-week rehabilitation program after THA, and the only differences between groups concern the use of gait-analysis technology and biofeedback. The main outcomes include changes in plantar-pressure-based gait parameters (mean foot pressure and load asymmetry) and standard clinical scores of hip function and symptoms. The study will also monitor safety, device-related events, walking speed, pain, and patient and therapist ratings of usability and satisfaction. The goal is to determine whether rehabilitation supported by the EUKINES insole system is at least as effective and safe as rehabilitation supported by a certified reference system and as standard care, and to explore the feasibility of using low-cost, printed-sensor technology for routine gait assessment and future telerehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedFirst Submitted
Initial submission to the registry
February 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 4, 2026
CompletedMarch 4, 2026
March 1, 2026
12 months
February 11, 2026
March 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in mean foot pressure (MFP) on the operated limb
Mean foot pressure (MFP) is defined as the average plantar pressure across all active sensing regions of the insole during the stance phase of gait, expressed in kilopascals. MFP will be recorded during standardized 10-meter walking trials using the EUKINES and/or reference insole systems, and session-level MFP will be calculated as the mean value across all valid steps. The primary analysis will compare changes in MFP on the operated limb over time and between rehabilitation arms.
Baseline (Week 0), Week 3, Week 6 after surgery
Change in load asymmetry between operated and non-operated limb
Load asymmetry will be quantified using plantar-pressure data from the EUKINES and/or reference insole systems as the difference or ratio between mean foot pressure on the operated and non-operated limb during standardized 10-meter walking trials. Reduced inter-limb asymmetry over time will be interpreted as improved functional load distribution after total hip arthroplasty.
Baseline (Week 0), Week 3, Week 6 after surgery
Change in Harris Hip Score (HHS)
The Harris Hip Score is a validated clinician-administered scale assessing pain, function, range of motion, and absence of deformity in patients after hip surgery. Total scores range from 0 to 100, with higher scores indicating better hip function. The primary analysis will compare changes in HHS from baseline to Week 6 between rehabilitation arms.
Baseline (preoperative or immediate postoperative) and Week 6 after surgery
Change in HOOS-12 total score
The HOOS-12 is a validated 12-item short form of the Hip Disability and Osteoarthritis Outcome Score that assesses pain, function, and quality of life in hip patients. Scores are transformed to a 0-100 scale, with higher scores indicating better outcomes. The main analysis will evaluate changes in HOOS-12 total score from baseline to Week 6, with reference to the minimal clinically important difference of approximately 9-12 points reported in the literature.
Baseline (preoperative or immediate postoperative) and Week 6 after surgery
Incidence of adverse events and device-related complications
Safety will be assessed by recording all adverse events, device-related complications, skin irritation, falls, or other medical incidents potentially associated with device use or the supplementary rehabilitation sessions. Events will be classified by severity, relationship to the device or intervention, and outcome.
From enrollment through Week 6 after surgery
Secondary Outcomes (7)
Preferred walking speed (10-Meter Walk Test)
Baseline, Week 3, Week 6
Change in maximal walking speed (10-Meter Walk Test)
Baseline, Week 3, Week 6
Change in spatiotemporal gait parameters derived from plantar-pressure insoles
Additional gait parameters (e.g., cadence, stance and swing phase duration, rollover time) will be derived from plantar-pressure time-series data and analyzed as exploratory secondary outcomes.
Change in hip pain intensity (VAS)
Baseline, Week 3, Week 6
Change in patient satisfaction with surgery and rehabilitation measured with a Visual Analogue Scale (VAS)
Week 3 and Week 6
- +2 more secondary outcomes
Study Arms (4)
EUKINES with biofeedback
EXPERIMENTALParticipants receive the structured postoperative rehabilitation program supported by the EUKINES plantar-pressure insole system with real-time biofeedback on gait parameters during the additional rehabilitation sessions.
EUKINES without biofeedback
EXPERIMENTALParticipants receive the structured postoperative rehabilitation program while wearing the EUKINES plantar-pressure insole system without real-time biofeedback; gait data are recorded for analysis only during the additional rehabilitation sessions.
Reference system with biofeedback
ACTIVE COMPARATORParticipants receive the structured postoperative rehabilitation program supported by a certified commercial plantar-pressure gait-analysis system providing real-time biofeedback on gait parameters during the additional rehabilitation sessions.
Standard rehabilitation
ACTIVE COMPARATORParticipants receive the same structured postoperative rehabilitation program without any gait-analysis device or biofeedback; rehabilitation is based on standard clinical practice at participating centers.
Interventions
Commercially available, certified plantar-pressure gait-analysis system used according to the manufacturer's recommendations to provide real-time biofeedback on gait parameters during rehabilitation sessions.
Wearable plantar-pressure insole system developed within the EUKINES project, consisting of thin-film printed pressure sensors, shoe-mounted electronic modules, and PC-based software for real-time gait data acquisition and visualization. In the biofeedback arm, real-time feedback on gait parameters is provided during rehabilitation sessions; in the non-biofeedback arm, data are recorded without feedback.
Standard postoperative rehabilitation program after total hip arthroplasty, delivered according to local clinical protocols and including six additional approximately 3-hour gait-focused rehabilitation sessions over 6 weeks, with progressive gait training, balance and coordination exercises, and functional mobility tasks.
Eligibility Criteria
You may qualify if:
- Age 18 years or older.
- Scheduled for primary total hip arthroplasty performed for advanced osteoarthritis or other degenerative hip disease.
- Willingness and ability to participate in the 6-week postoperative rehabilitation program and follow-up assessments.
- Ability to understand study information and provide written informed consent.
You may not qualify if:
- Coexisting medical conditions that may significantly affect rehabilitation outcomes or gait (e.g., severe neurological disorders, major lower-limb joint trauma, other significant musculoskeletal pathology).
- Cognitive impairment or psychiatric conditions that would preclude effective cooperation with the rehabilitation and research team.
- Any contraindication to participation in additional gait training sessions or use of the insole-based gait-analysis systems as judged by the treating physician.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardinal Stefan Wyszynski University in Warsaw, Collegium Medicum - Affiliated Orthopaedic Department
Warsaw, Masovian Voivodeship, 01-938, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrzej Kotela
Cardinal Stefan Wyszynski University in Warsaw
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors responsible for postoperative follow-up visits and clinical evaluations are blinded to group allocation. Patients, care providers, and rehabilitation staff are aware of the assigned intervention because of the visible use or non-use of gait-analysis devices.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2026
First Posted
March 4, 2026
Study Start
December 15, 2024
Primary Completion
November 30, 2025
Study Completion
November 30, 2025
Last Updated
March 4, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because there is no dedicated infrastructure or funding for long-term controlled access data sharing beyond the requirements for publication and regulatory reporting.